LEAP THERAPEUTICS INC. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 77.13. In total, the insiders bought 11 905 606 and sold 688 106 LPTX shares in the last 100 trades.

Insider Power

(Last 100 transactions)
77.13
Buy 11 905 606 Shares
Sell 688 106 Shares

Historical Insider Trades

Date Type Action Person Amount
Apr 10, 2024 Common Stock Buy Gilead Sciences, Inc. 0
Jan 29, 2024 Stock Option (Right to Buy) Buy Mashiach Nissim 25 000
Jan 29, 2024 Stock Option (Right to Buy) Buy Dietz Thomas John 30 000
Jan 29, 2024 Stock Option (Right to Buy) Buy Schilsky Richard 25 000
Jan 29, 2024 Employee Stock Option (Right to Buy) Buy Granfield Christine 85 000
Jan 29, 2024 Employee Stock Option (Right to Buy) Buy Baum Jason 85 000
Jan 29, 2024 Stock Option (Right to Buy) Buy Richard Christian M 25 000
Jan 29, 2024 Employee Stock Option (Right to Buy) Buy O'mahony John Mark 85 000
Jan 29, 2024 Employee Stock Option (Right to Buy) Buy Sirard Cynthia 85 000
Jan 29, 2024 Stock Option (Right to Buy) Buy Martin Patricia A. 25 000
Jan 29, 2024 Employee Stock Option (Right to Buy) Buy Lawlor Augustine 85 000
Jan 29, 2024 Stock Option (Right to Buy) Buy Loscalzo Joseph 25 000
Jan 29, 2024 Stock Option (Right to Buy) Buy Mirabelli Christopher 85 000
Jan 29, 2024 Employee Stock Option (Right to Buy) Buy Onsi Douglas E 170 000
Jan 29, 2024 Stock Option (Right to Buy) Buy Li William 25 000
Jan 29, 2024 Stock Option (Right to Buy) Buy Cavanaugh James H 25 000
Jan 26, 2024 Common Stock Buy Mirabelli Christopher 5 000
Jan 26, 2024 Restricted Stock Units Sell Mirabelli Christopher 5 000
Jan 26, 2024 Common Stock Buy O'mahony John Mark 5 000
Jan 26, 2024 Restricted Stock Units Sell O'mahony John Mark 5 000
Jan 26, 2024 Common Stock Buy Sirard Cynthia 5 000
Jan 26, 2024 Restricted Stock Units Sell Sirard Cynthia 5 000
Jan 26, 2024 Common Stock Buy Lawlor Augustine 5 000
Jan 26, 2024 Restricted Stock Units Sell Lawlor Augustine 5 000
Jan 26, 2024 Common Stock Buy Onsi Douglas E 7 500
Click to get the best stock tips daily for free!

About LEAP THERAPEUTICS INC.

LEAP THERAPEUTICS INC. Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and com... LPTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT